info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)

Researchers from Brigham Develop AI to Streamline a Lung Cancer Radiation Therapy

By Indu Tyagi Ketan , 28 October, 2022

Lung cancer is the second most common cancer worldwide. According to World Health Organization, in 2020, more than 2.2 million new cases of lung cancer were registered across the globe and accounted for around 10 million deaths.

The standard treatment known for lung cancer is radiation therapy or radiotherapy. It is estimated that more than 60% of lung cancer patients undergo radiotherapy at least once. According to medical experts, planning radiation therapy is a time-consuming and manual process that requires highly skilled resources to target the malignant tumors on Computed Tomography (CT) scans. Thus, to improve the function of radiotherapy, a team of scientists from Brigham and Women’s Hospital, Massachusetts, US, developed a deep learning algorithm. This algorithm allows the identification and segmentation of non-small cell lung cancer (NSCLC) tumors on CT scans within a few seconds. The team also reported that the algorithm’s clinician worked 65% quicker with 32% less variation than the non-users. The study is published in the Lancet Digital Health journal.

To train the AI model to distinguish tumors from non-cancerous tissues, the team used CT scans of 787 patients in the study. This algorithm was further tested with CT images from more than 1,400 patients. Upon completion of training, the researchers asked eight radiation oncologists to perform the segmentation tasks manually. They were also made to edit and rate segmentations prepared by an AI algorithm or another physician without knowing who made each segmentation. The analysis revealed no discernible performance difference between segmentations created by a human and AI algorithm collaboration and those created only by human medical specialists.

According to the researchers, applying this AI model in planning radiation therapy will benefit the patients as the algorithm will provide high-quality tumor segmentation. This will also accelerate the treatment decision-making process. In addition to providing advantages to the patients, the algorithm also benefits clinicians. It was reported that, with this algorithm, the clinicians could reduce their task time and difficulty along with high satisfaction.

                        Distribution of Cases And Death,Worldwise,2020

2022.jpg

Latest News

2025.png
Quadric and Denso Team Up to Progress Automotive AI Semiconductors for 2025

The automotive industry will benefit significantly from strategic partnerships in artificial intelligence (AI) and its use in cars. AI integration into automobiles is projected to improve considerably in the year 2025 due to the formation of various…

Read More

2024.png
Semiconductor Trade Restrictions Threaten EV, AI, and Industrial Progress in 2025

In 2025, the global semiconductor industry is already grappling with new and complex challenges emanating from the trade wars and policy changes between the United States and China. The semiconductor industry, an essential backbone of technology…

Read More

2030.png
Surge in Demand for Semiconductors in 2025 Driven by Boom of Generative AI

The rapid use of generative artificial intelligence (AI) in 2025 has profoundly affected the semiconductor sector, resulting in unprecedented growth for advanced chip technologies. According to estimates made by the Capgemini Research Institute, this…

Read More

condition.png
Texas Faces Challenges to Balance Grid Security and AI Boom in 2025

Texas will face an emerging challenge in 2025 as the electricity grid experiences unprecedented strain from the rapid expansion of artificial intelligence (AI) data centers. Power usage has increased due to technology firms' indiscriminate placement…

Read More

Stocks.png
Tech Turmoil in 2025: Magnificent Seven Stocks Slide as Tesla Leads Market Decline

With the "Magnificent Seven”- Apple, Microsoft, Amazon, Alphabet, Meta, Nvidia, and Tesla leading the fall, the US stock market saw a significant dip in early 2025. Usually seen as market drivers, these IT behemoths found themselves in the correction…

Read More

Author Pic
Indu Tyagi Ketan

Chief Strategy Officer